Suppr超能文献

间充质干细胞干性和治疗效力的增强剂。

Enhancers of mesenchymal stem cell stemness and therapeutic potency.

机构信息

Department of Immunology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.

Department of Immunology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China; Department of Therapy and Nursing, Bashkir State Medical University, Ufa 450008, Russia.

出版信息

Biomed Pharmacother. 2023 Jun;162:114356. doi: 10.1016/j.biopha.2023.114356. Epub 2023 Apr 9.

Abstract

Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a range of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Multiple preclinical investigations and clinical trials employed enhanced MSCs-dependent therapies in treatment of inflammatory and degenerative diseases. They have demonstrated considerable and prospective therapeutic potentials even though the large-scale use remains a problem. Several strategies have been used to improve the therapeutic potency of MSCs in cellular therapy. Treatment of MSCs utilizing pharmaceutical compounds, cytokines, growth factors, hormones, and vitamins have shown potential outcomes in boosting MSCs' stemness. In this study, we reviewed the current advances in enhancing techniques that attempt to promote MSCs' therapeutic effectiveness in cellular therapy and stemness in vivo with potential mechanisms and applications.

摘要

间充质干细胞(MSCs)是多能基质细胞,可分化为多种细胞类型,包括成骨细胞、软骨细胞、肌细胞和脂肪细胞。多项临床前研究和临床试验采用增强的 MSCs 依赖性疗法治疗炎症和退行性疾病。尽管大规模使用仍然存在问题,但它们已显示出相当大的和有前景的治疗潜力。已经使用了几种策略来提高细胞治疗中 MSCs 的治疗效力。利用药物化合物、细胞因子、生长因子、激素和维生素治疗 MSCs 已显示出在增强 MSCs 的干性方面具有潜在效果。在这项研究中,我们综述了目前增强技术的进展,这些技术试图促进细胞治疗中 MSCs 的治疗效果和体内干性,并探讨了其潜在的机制和应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验